Marc Potenza, PhD, MD
Steven M. Southwick Professor of Psychiatry and Professor in the Child Study Center and of NeuroscienceCards
About
Research
Overview
Dr. Potenza's research has focused on the neurobiology and treatment of substance and non-substance addictions and other disorders characterized by impaired impulse control, particularly the disorders characterized in DSM-IV as “Impulse Control Disorders Not Elsewhere Classified” and in DSM-5 and ICD-11 as behavioral addictions. He has focused on internet use behaviors and disorders such as gaming disorder and problematic pornography use, as well as compulsive sexual behavior disorder, binge eating disorder and food addiction. He has investigated mechanisms underlying the treatment of cocaine and opioid use disorders, as well as the neural correlates of prenatal cocaine use. Much of this work has focused on understanding clinical and neurobiological underpinnings of these disorders and experiences, and their co-occurrences with other mental health disorders, in order to advance prevention and treatment strategies. Dr. Potenza's research has applied brain imaging, genetic, epidemiological and clinical trials methodologies to gain knowledge and improve prevention and treatment strategies for addictive disorders. This work has also involved a specific focus on gender and identifying potential intermediary phenotypes, like facets of impulsivity, that may in part explain the high rates of co-occurrence between addictive disorders and other mental health conditions, and might represent novel targets for prevention and treatment strategies.
Medical Subject Headings (MeSH)
Academic Achievements & Community Involvement
News
News
- November 14, 2024Source: The New York Times
How Tech Created a ‘Recipe for Loneliness’
- October 24, 2024
Carolyn M. Mazure Receives Elga R. Wasserman Award
- October 24, 2024
Women’s Health Research at Yale Welcomes Undergraduate Fellows
- October 16, 2024Source: Biological Psychiatry
Vitamin D’s Capacity to Increase Amphetamine-Induced Dopamine Release in Healthy Humans: A Clinical Translational [11C]-PHNO Positron Emission Tomography Study